BioSpace News Archive

Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced that it has initiated development of a recombinant subunit vaccine for 2019-nCoV, the newly identified coronavirus that is believed to have originated from Wuhan, China.

Immuron Limited announced the sales results of its commercially available and over-the-counter gastrointestinal and digestive health supplement Travelan® for the first half of fiscal year 2020 ending on December 31, 2019.

(EcoGen), the leading vertically-integrated manufacturer and supplier of hemp-derived specialty ingredients, proprietary formulations, and private-label finished products in the United States, announced today the closing of a $40 million private placement.

Versatope Therapeutics, Inc. announced four new members to their Scientific Advisory Board who are leaders in the field infectious disease research and influenza vaccines: Drs. Frederick G. Hayden, Stacey Schultz-Cherry, David Topham and Ralph Tripp.

Acerus Pharmaceuticals Corporation announced the acceptance of a scientific abstract reporting the results of the NATESTO® Spermatogenesis Study by the Endocrine Society for presentation at their Annual Meeting.

Alpha’s Latest Release Merely Resurfaces Earlier “Proposal” in its Entirety, Just with a New Expiration Date – This is Meaningless and Does Nothing to Improve its Poor, Contingency-Laden Terms

Kaneka Americas Holding, Inc., achieves Health Canada Class III approval for Floradapt™ Cardio under the Natural Health Products Directorate (NHPD) as identified by the Natural Product Number (NPN) 80096187.

NovuHealth, the healthcare industry’s leading consumer engagement company, today announced its new Member Satisfaction Solution to help Medicare Advantage plans enhance the member experience and boost satisfaction

Imprivata®, the leader in digital identity company for healthcare, today announced the acquisition of GroundControl Solutions, Inc., a leader in cloud-based automation software for provisioning shared mobile devices.

Ocean Bio-Chem, Inc. (NASDAQ: OBCI) today announced that its’ subsidiary Star brite, Inc product PERFORMACIDE® is registered with the U.S. Environmental Protection Agency (EPA) as a virucide effective against coronavirus, when used as directed.